Concordia, Ono in deal for salirasib

Concordia Pharmaceuticals Inc. (Fort Lauderdale, Fla.) granted Ono Pharmaceutical Co. Ltd. (Tokyo:4528; Osaka:4528) exclusive rights to develop and commercialize salirasib in Japan. The Ras antagonist...